Literature DB >> 2860940

Pharmacological activity of ACC-7513, a selective alpha-adrenoceptor and 5-hydroxytryptamine receptor blocking agent.

W G Anderson, S T Kam.   

Abstract

The pharmacological activity of N-[2-(2,6-dimethoxyphenoxy) ethyl]-2-(2-methoxyphenoxy) ethanaminium chloride (ACC-7513) was determined in isolated smooth and cardiac muscle and its effect on blood pressure and heart rate assessed in the spontaneously hypertensive rat (SHR). ACC-7513 was found to be a potent alpha-adrenoceptor blocking agent (pA2:8.33) and a 5-hydroxytryptamine (5-HT) antagonist (pA2:7.01), both in rabbit aortic strips. The affinity for alpha-adrenoceptors was about 20 times greater than that for 5-HT-receptors. High concentrations of ACC-7513 did not block histamine in rabbit aortic strips, or beta 1- or beta 2-adrenoceptor responses induced by isoprenaline in guinea-pig right atria and trachea, respectively, but did block cholinoceptor responses induced by carbachol in rat uterus, non-competitively. High concentrations of ACC-7513 also produced sino-atrial depression in guinea-pig right atria and direct relaxation of depolarized rabbit aortic strips. ACC-7513 depressed blood pressure of conscious SHRs and produced a reflex increase in heart rate. The reductions in pressure were modest and of short duration. It is concluded that: (a) ACC-7513 is a potent, selective alpha-adrenoceptor and 5-HT receptor antagonist; and (b) ACC-7513 is not likely to be useful in the treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860940      PMCID: PMC1987049          DOI: 10.1111/j.1476-5381.1985.tb17373.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Spiral-cut strip of rabbit aorta for in vitro studies of responses of arterial smooth muscle.

Authors:  R F FURCHGOTT
Journal:  Methods Med Res       Date:  1960

2.  The alpha-adrenoceptor blocking effects of a new benzodioxane.

Authors:  D R Mottram; H Kapur
Journal:  J Pharm Pharmacol       Date:  1975-04       Impact factor: 3.765

3.  Receptor interaction for the alpha-antagonist WB4101 (2(N[2,6-dimethyoxyphenoxyethyl])amino-methyl-1,4-benzodioxane).

Authors:  H Kapur; D R Mottram; P N Green
Journal:  J Pharm Pharmacol       Date:  1978-04       Impact factor: 3.765

4.  Further studies on receptor interaction for the alpha-antagonist WB 4101.

Authors:  H Kapur; P N Green; D R Mottram
Journal:  J Pharm Pharmacol       Date:  1979-03       Impact factor: 3.765

5.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

6.  Blockade by WB 4101 of alpha-adrenoceptors in the rat vas deferens and guinea-pig taenia caeci.

Authors:  M Butler; D H Jenkinson
Journal:  Eur J Pharmacol       Date:  1978-12-01       Impact factor: 4.432

7.  Vascular reactivity to 5-hydroxytryptamine and hypertension in the rat.

Authors:  G Haeusler; L Finch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

8.  The pharmacological differentiation of adrenergic receptors.

Authors:  R F Furchgott
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

9.  Prazosin and its analogues UK-18,596 and UK-33,274: a comparative study on cardiovascular effects and alpha-adrenoceptor blocking activities.

Authors:  P B Timmermans; H Y Kwa; F K Ali; P A van Zwieten
Journal:  Arch Int Pharmacodyn Ther       Date:  1980-06

10.  Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta.

Authors:  E Apperley; P P Humphrey; G P Levy
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.